Literature DB >> 16359327

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.

Matthew C Anderton1, Sanjib Bhakta, Gurdyal S Besra, Peter Jeavons, Lindsay D Eltis, Edith Sim.   

Abstract

Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferase whose gene is predicted to occur within a six-gene operon. Deletion of the nat gene caused an extended lag phase in M. bovis BCG and a cell morphology associated with an altered pattern of cell wall mycolates. Analysis of cDNA from M. bovis BCG shows that during in vitro growth all the genes in the putative nat operon are expressed and the open reading frames are contiguous, supporting the existence of an operon. Two genes in the operon, Mb3599c and Mb3600c, are predicted to encode homologues of enzymes annotated as a 2,3-dihydroxybiphenyl 1,2-dioxygenase (bphC5) and a 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (bphD2), respectively, in Rhodococcus RHA1. As predicted, M. bovis BCG cell lysates metabolized the BphC substrate 2,3-dihydroxybiphenyl (2,3-DHB) to 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid (HOPDA), a BphD substrate, which was subsequently hydrolysed. Immunoprecipitation of the BphD homologue from these lysates led to an accumulation of HOPDA. M. bovis BCG growth on both solid and liquid media was inhibited with either 2,3-DHB or an inhibitor of BphC, 3-chlorocatechol (3-CC). In addition, incubation with 2,3-DHB affects the lipid composition of the cell wall resulting in a diminished level of mycolates and an altered cell morphology similar to the Deltanat strain. We propose the enzymes encoded by the putative operon have a similar endogenous role to that of the NAT enzyme and are part of a pathway important for cell wall synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16359327     DOI: 10.1111/j.1365-2958.2005.04945.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  21 in total

1.  Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.

Authors:  Elizabeth Fullam; Akane Kawamura; Helen Wilkinson; Areej Abuhammad; Isaac Westwood; Edith Sim
Journal:  Protein J       Date:  2009-08       Impact factor: 2.371

2.  Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.

Authors:  Areej M Abuhammad; Edward D Lowe; Elizabeth Fullam; Martin Noble; Elspeth F Garman; Edith Sim
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

3.  Kinetic and structural insight into the mechanism of BphD, a C-C bond hydrolase from the biphenyl degradation pathway.

Authors:  Geoff P Horsman; Jiyuan Ke; Shaodong Dai; Stephen Y K Seah; Jeffrey T Bolin; Lindsay D Eltis
Journal:  Biochemistry       Date:  2006-09-19       Impact factor: 3.162

4.  A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.

Authors:  Robert Van der Geize; Katherine Yam; Thomas Heuser; Maarten H Wilbrink; Hirofumi Hara; Matthew C Anderton; Edith Sim; Lubbert Dijkhuizen; Julian E Davies; William W Mohn; Lindsay D Eltis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

5.  Arylamine N-acetyltransferase responsible for acetylation of 2-aminophenols in Streptomyces griseus.

Authors:  Hirokazu Suzuki; Yasuo Ohnishi; Sueharu Horinouchi
Journal:  J Bacteriol       Date:  2006-12-08       Impact factor: 3.490

6.  The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.

Authors:  Vasiliki Garefalaki; Evanthia Kontomina; Charalambos Ioannidis; Olga Savvidou; Christina Vagena-Pantoula; Maria-Giusy Papavergi; Ioannis Olbasalis; Dionysios Patriarcheas; Konstantina C Fylaktakidou; Tamás Felföldi; Károly Márialigeti; Giannoulis Fakis; Sotiria Boukouvala
Journal:  World J Microbiol Biotechnol       Date:  2019-10-31       Impact factor: 3.312

Review 7.  New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.

Authors:  E Jeffrey North; Mary Jackson; Richard E Lee
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.

Authors:  Isaac M Westwood; Sanjib Bhakta; Angela J Russell; Elizabeth Fullam; Matthew C Anderton; Akane Kawamura; Andrew W Mulvaney; Richard J Vickers; Veemal Bhowruth; Gurdyal S Besra; Ajit Lalvani; Stephen G Davies; Edith Sim
Journal:  Protein Cell       Date:  2010-03-18       Impact factor: 14.870

9.  Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.

Authors:  Ali Ryan; Elena Polycarpou; Nathan A Lack; Dimitrios Evangelopoulos; Christian Sieg; Alice Halman; Sanjib Bhakta; Olga Eleftheriadou; Timothy D McHugh; Sebastian Keany; Edward D Lowe; Romain Ballet; Areej Abuhammad; William R Jacobs; Alessio Ciulli; Edith Sim
Journal:  Br J Pharmacol       Date:  2017-05-09       Impact factor: 8.739

Review 10.  Arylamine N-acetyltransferases in mycobacteria.

Authors:  Edith Sim; James Sandy; Dimitrios Evangelopoulos; Elizabeth Fullam; Sanjib Bhakta; Isaac Westwood; Anna Krylova; Nathan Lack; Martin Noble
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.